Amelia M Stanton

Dr. Amelia M Stanton

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAmelia M Stanton
Amelia M Stanton
ABAbigail W. Batchelder
Abigail W. Batchelder
NKNorik Kirakosian
Norik Kirakosian
JSJames Scholl
James Scholl
DKDana King
Dana King
COConall O’cLeirigh
Conall O’cLeirigh
Mental health disparities among transgender and gender diverse (TGD) populations have been documented. However, few studies have assessed differences in mental health symptom severity, substance use behavior severity, and engagement in care across TGD subgroups. Using data from the electronic health record of a community health center specializing in sexual and gender minority health, we compared the (1) severity of self-reported depression, anxiety, alcohol use, and other substance use symptoms; (2) likelihood of meeting clinical thresholds for these disorders; and (3) number of behavioral health and substance use appointments attended among cisgender, transgender, and non-binary patients. Participants were 29,988 patients aged ≥18 who attended a medical appointment between 2015 and 2018. Depression symptom severity (F= 200.6, p < .001), anxiety symptom severity (F= 102.8, p < .001), alcohol use (F= 58.8, p < .001), and substance use (F= 49.6, p < .001) differed significantly by gender. Relative to cisgender and transgender individuals, non-binary individuals are at elevated risk for depression, anxiety, and substance use disorders. Gender was also associated with differences in the number of behavioral health (χ2= 51.5, p < .001) and substance use appointments (χ2= 39.3, p < .001) attended. Engagement in treatment among certain gender groups is poor; cisgender women and non-binary patients assigned male at birth were the least likely to have attended a behavioral health appointment, whereas transgender men and cisgender women had attended the lowest number of substance use appointments. These data demonstrate the importance of (1) assessing gender diversity and (2) addressing the barriers that prevent TGD patients from receiving affirming care.

1 August 2015 in Child Abuse & Neglect
Verified
Journal Article
Closed access
ASAmelia M Stanton
Amelia M Stanton
RBRyan L. Boyd
Ryan L. Boyd
CPCarey S. Pulverman
Carey S. Pulverman
CMCindy M. Meston
Cindy M. Meston

8 March 2022 in International Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
CPChristina Psaros
Christina Psaros
ASAmelia M Stanton
Amelia M Stanton
GRGreer A. Raggio
Greer A. Raggio
NMNzwakie Mosery
Nzwakie Mosery
GGGeorgia R. Goodman
Georgia R. Goodman
SSSteven A. Safren
Steven A. Safren

17 October 2022 in Journal of the International AIDS Society
Verified
Journal Article
Open access
ASAmelia M Stanton
Amelia M Stanton
COConall O'CLeirigh
Conall O'CLeirigh
LKLucia Knight
Lucia Knight
DDDvora L. Joseph Davey
Dvora L. Joseph Davey
LMLandon Myer
Landon Myer
CPChristina Psaros
Christina Psaros
Introduction: Pregnant and postpartum women (PPW) in sub‐Saharan Africa are at disproportionately high risk of HIV infection compared to non‐pregnant women. When used consistently, pre‐exposure prophylaxis (PrEP) can prevent HIV acquisition and transmission to the foetus or infant during these critical periods. Recent studies have demonstrated associations between mental health challenges (e.g. depression and traumatic stress associated with intimate partner violence) and decreased PrEP adherence and persistence, particularly among adolescents, younger women and women in the postpartum period. However, mental health is not currently a major focus of PrEP implementation research and programme planning for PPW.Discussion: PrEP implementation programmes for PPW need to assess and address mental health barriers to consistent PrEP use to ensure effectiveness and sustainability in routine care. We highlight three key research priorities that will support PrEP adherence and persistence: (1) include mental health screening tools in PrEP implementation research with PPW, both to assess the feasibility of integrating these tools into routine antenatal and postpartum care and to ensure that limited resources are directed towards women whose symptoms may interfere most with PrEP use; (2) identify cross‐cutting, transdiagnostic psychological mechanisms that affect consistent PrEP use during these periods and can realistically be targeted with intervention in resource‐limited settings; and (3) develop/adapt and test interventions that target those underlying mechanisms, leveraging strategies from existing interventions that have successfully mitigated mental health barriers to antiretroviral therapy use among people with HIV.Conclusions: For PPW, implementation of PrEP should be guided by a robust understanding of the unique psychological difficulties that may act as barriers to uptake, adherence and persistence (i.e. sustained adherence over time). We strongly encourage PrEP implementation research in PPW to incorporate validated mental health screening tools and ultimately treatment in routine antenatal and postnatal care, and we stress the potential public health benefits of identifying women who face mental health barriers to PrEP use.

28 January 2021 in International Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
ASAmelia M Stanton
Amelia M Stanton
JLJasper S. Lee
Jasper S. Lee
MWMegan R. Wirtz
Megan R. Wirtz
LALena S. Andersen
Lena S. Andersen
JJJohn Joska
John Joska
COConall O’cLeirigh
Conall O’cLeirigh

4 November 2019 in Current Sexual Health Reports
Verified
Journal Article
Closed access
PDF file
ASAmelia M Stanton
Amelia M Stanton
GGGeorgia Goodman
Georgia Goodman
SLSara E. Looby
Sara E. Looby
GRGregory K. Robbins
Gregory K. Robbins
CPChristina Psaros
Christina Psaros